170 related articles for article (PubMed ID: 3139519)
21. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
Yuan ZY; Xu RH; He YJ; Guan ZZ
Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996
[TBL] [Abstract][Full Text] [Related]
22. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Alliot C
J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
[No Abstract] [Full Text] [Related]
23. [Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Takagi T; Sakai C; Oguro M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):917-20. PubMed ID: 1605671
[No Abstract] [Full Text] [Related]
24. Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status.
Haak HL; Gerrits WB; Wijermans PW; Kerkhofs H
Neth J Med; 1993 Apr; 42(3-4):122-7. PubMed ID: 8316324
[TBL] [Abstract][Full Text] [Related]
25. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.
Lyman GH; Dale DC; Friedberg J; Crawford J; Fisher RI
J Clin Oncol; 2004 Nov; 22(21):4302-11. PubMed ID: 15381684
[TBL] [Abstract][Full Text] [Related]
26. [Combined CHOP and radiotherapy in non-Hodgkin's lymphoma of unfavorable histology].
Tominaga S; Kondo M
Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2249-56. PubMed ID: 3819551
[No Abstract] [Full Text] [Related]
27. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
28. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
[No Abstract] [Full Text] [Related]
29. [Comparison of two multi-drug chemotherapy regimens based on mitoxantrone and epirubicin in 44 patients with non-Hodgkin's lymphoma].
Gao HR
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):287-90. PubMed ID: 1806350
[TBL] [Abstract][Full Text] [Related]
30. The treatment of non-Hodgkin's lymphoma with mitoxantrone-containing regimens.
Sonneveld P
Semin Oncol; 1995 Feb; 22(1 Suppl 1):29-31. PubMed ID: 7863349
[No Abstract] [Full Text] [Related]
31. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
Salloum E; Levin M
N Engl J Med; 1993 Aug; 329(8):581; author reply 581-2. PubMed ID: 8336764
[No Abstract] [Full Text] [Related]
32. [VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report].
Ishii K; Yamamoto Y; Shigeki T; Kitayama H; Hayashi K; Hirose A; Ohta T; Mugitani A; Fujino H; Yagi T; Hirai M; Teshima H; Katsurada T; Urase F; Kitajima H
Gan To Kagaku Ryoho; 2005 Jan; 32(1):39-44. PubMed ID: 15675580
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study Group.
Bezwoda W; Rastogi RB; Erazo Valla A; Diaz-Maqueo JC; Pavlovsky S; Morioka H; Resegotti L; Rueckle H; Somoza N; Moreno-Nogueira JA
Eur J Cancer; 1995 Jun; 31A(6):903-11. PubMed ID: 7646919
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized study.
Takagi T; Sampi K; Sawada U; Sakai C; Oguro M
Int J Hematol; 1993 Jan; 57(1):67-71. PubMed ID: 8477064
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma].
Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A
Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516
[No Abstract] [Full Text] [Related]
36. [Effect of granulocyte colony-stimulating factor after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection].
Navarro JT; Ribera JM; Gómez-Espuch J; Feliu E
Med Clin (Barc); 1996 Jun; 107(3):118-9. PubMed ID: 8754503
[No Abstract] [Full Text] [Related]
37. [Study of optimal CHOP dose ranges for elderly patients with non-Hodgkin's lymphoma].
Mori M; Murai Y; Suzuki K; Nonaka Y; Sato H; Tomiyama J; Takagi T; Muto Y; Kashimura M
Rinsho Ketsueki; 1999 Mar; 40(3):199-204. PubMed ID: 10222626
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of non-Hodgkin's lymphoma with CHOP therapy: analysis of lymphocyte subsets and interleukin 2 activity during CHOP therapy].
Suzuki Y; Yamada H; Saito Y; Nakajima H; Shinozaki T; Isono M; Chikada K; Maeno H; Sawaki S; Yamada K
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1225-31. PubMed ID: 3491170
[No Abstract] [Full Text] [Related]
39. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
Pawelski S; Konopka L; Pakulska J; Gutkowska J
Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
[No Abstract] [Full Text] [Related]
40. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
